Stay updated on Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page displays Revision: v3.4.3, replacing Revision: v3.4.2. No study content or functionality is altered.
    Difference
    0.1%
    Check dated 2026-03-11T23:41:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; notices about government funding lapses and the prior v3.4.1 revision were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:07:21.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A system notice about a lapse in government funding and NIH operating status was added. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:16:20.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle, and adds new footer/version metadata labels: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; the older label Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:56:10.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.3 to v3.3.4; there are no changes to study content or key information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:40:36.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new Locations section has been added with Texas listed as a site. The HHS Vulnerability Disclosure and Texas Locations entries were removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:50:16.000Z thumbnail image

Stay in the know with updates to Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.